Search Results

You are looking at 61 - 70 of 133 items for :

  • "chronic hepatitis C" x
  • Refine by Access: All Content x
Clear All

215 221 Jármay, K., Karácsony, G., Nagy, A. és mtsa: Changes in lipid metabolism in chronic hepatitis C. World J. Gastroent., 2005, 11 , 422

Restricted access

. 1), 34–59. 10 Razavi, H., Elkhoury, A. C., Elbasha, E., et al.: Chronic hepatitis C virus (HCV) disease burden and cost in the United States

Restricted access

2001 Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial Lancet 358 958 – 965 . [5]. M. W. Fried M. L. Shiffman K. R. Reddy 2002

Restricted access
Orvosi Hetilap
Authors: Balázs Nemes, Enikő Sárváry, Zsuzsa Gerlei, János Fazakas, Attila Doros, Andrea Németh, Dénes Görög, Imre Fehérvári, Zoltán Máthé, Zsuzsa Gálffy, Alajos Pár, János Schuller, László Telegdy, János Fehér, Gábor Lotz, Zsuzsa Schaff, Péter Nagy, Jenő Járay, and Gabriella Lengyel

, V., Burgess, C., Drucker, E. és mtsai: Epidemiology of chronic hepatitis C vírus infection in sub-Saharan Africa. Lancet Infect. Dis., 2002, 2 , 293–302. Drucker E

Restricted access
Hungarian Medical Journal
Authors: Nimzing G. Ladep, Oche O. Agbaji, Patricia A. Agaba, Muazu A. Mohammed, Godwin E. Imade, and John A. Idoko

Garcia-Samaniego, J., Soriano, V., Castilla, J. et al.: Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C. The hepatitis/HIV Spanish Study Group. Am. J. Gastroenterol, 1997, 92 , 1130

Restricted access
Orvosi Hetilap
Authors: Balázs Nemes, Fanni Gelley, Gergely Zádori, Katalin Földes, Gábor Firneisz, Dénes Görög, Imre Fehérvári, László Kóbori, Zsuzsanna Gerlei, János Fazakas, Simon Pápai, Attila Doros, Péter Nagy, Gabriella Lengyel, Zsuzsa Schaff, and Enikő Sárváry

1464 1472 Ma, Y., Yan, W. W.: Chronic hepatitis C virus infection and post-transplantation diabetes mellitus. World J. Gastroenterol., 2005, 11 , 6085

Open access

Manns, M. P., McHutchison, J. G., Gordon, S. C. és mtsai: Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet, 2001, 358 , 958

Restricted access

Arif, A., Levine, R. A., Sanderson, S. O., Bank, L., Velu, R. P., Shah, A., Mahl, T. C., Gregory, D. H. (2003) Regression of fibrosis in chronic hepatitis C after therapy with interferon and ribavirin. Dig

Restricted access

Inoue, K., Sekiyama, K., Yamada, M. et al.: Combined interferon alpha2b and cyclosporin A in the treatment of chronic hepatitis C: controlled trial. J. Gastroenterol., 2003, 38 , 567–72. Yamada M

Restricted access

hepatitis C. Aliment Pharmacol. Ther, 2004, 19 , 1159–1172. Sanders G. D. Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic

Restricted access